Yüklüyor......
Use and Spending on Biologic Disease-modifying Anti-rheumatic Drugs for Rheumatoid Arthritis among U.S. Medicare Beneficiaries
OBJECTIVES: Biologic therapies have assumed an important role in treating rheumatoid arthritis (RA). We sought to investigate use, spending, and patient cost-sharing for Medicare beneficiaries using biologic drugs for RA, comparing patients exposed to minimal cost-sharing because of a Part D low-inc...
Kaydedildi:
| Yayımlandı: | Arthritis Care Res (Hoboken) |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4573380/ https://ncbi.nlm.nih.gov/pubmed/25776035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.22580 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|